HIV in the ICU
Should a patient’s HIV seropositivity disqualify the person from admission into an ICU? Individual hospitals and regional groups need to identify poor prognostic features and develop their own triage guidelines.
Most developing countries are not able to provide the patient with maintenance HAART once discharged from the ICU. Should this situation change, will providing expensive high-technology treatment to previously unrecognized as well as known AIDS patients become standard of care in developing countries?
How can one develop practices that do not discriminate against the HIV-infected while not squeezing out the HIV-non-infected?
What should be the relation and balance between a country’s efforts at preventing HIV infection and providing adequate care for those who have been infected?
KeywordsHuman Immunodeficiency Virus Human Immunodeficiency Virus Infection Lactic Acidosis Human Immunodeficiency Virus Testing Nucleoside Reverse Transcriptase Inhibitor
Unable to display preview. Download preview PDF.
- 3.Pallela FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–860.Google Scholar
- 5.United Nations AIDS Programme. HIV/AIDS: the global epidemic. Geneva: United Nations AIDS Programme, 1998.Google Scholar
- 9.Kale R. Commentary: failing to seek patients’ consent to research is always wrong. BMJ 1997; 314:1081–1082.Google Scholar
- 10.Bhagwanjee S, Muckart DJJ, Jeena PM, Moodley P. Commentary: why we did not seek informed consent before testing patients for HIV. BMJ 1997; 314:1082–1083.Google Scholar
- 11.Seedat YK. Commentary: no simple and absolute ethical rule exists for every conceivable situation. BMJ 1997; 314: 1083–1084.Google Scholar
- 14.Anonymous. All treatment and trials must have informed consent. BMJ 1997; 314:1134–1135.Google Scholar
- 21.Schleicher GK, Richards GA, Black A. The effect of HIV on the outcome of patients admitted to the ICU with Guillain-Barre syndrome. Abstract 58; Combined Congress of the South African Thoracic Society and Critical Care Society of South Africa, Sun City 2002.Google Scholar
- 27.Brinkman K, Vrouenraets S, Kauffmann R, Weigel HM, Frissen PHJ. Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis. AIDS 2001; 14: 2801–2802.Google Scholar
- 30.Centers for Disease control and Prevention. Updated U. S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post-exposure prophylaxis. MMWR 2001; 50: (No RR-11):1–52.Google Scholar
- 34.Transmission of HIV from an infected surgeon to a patient in France. Communicable Disease Report Weekly 1997 7: 17.Google Scholar